Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Mutuum Finance (MUTM) Progresses Toward Q4 2025 Testnet Launch With $17.6 Million Raised
-
Kuardin Sets a New Benchmark for Real-World Integration in Digital Commerce
-
Cardano Price Prediction Revised Downwards as All Eyes Turn to Digitap’s ($TAP) Path to $20
-
ChillPlay Games announces major overhaul of “Over Hit: Hero Fight” surpassing 50,000 downloads and introducing AI Node powered by Claude AI and MCP
-
DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with metastatic triple-negative brea
-
World Winter Sports Expo 2025 Officially Opened
-
FBS AI Assistant Helps Traders Skip Market Noise and Focus on Strategy
-
Corcept Presents ESMO 2025 Late-Breaker: Relacorilant Demonstrates Benefit in Patients with Platinum-Resistant Ovarian Cancer with Prior PARP Inhibitor Treatment
-
ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy
-
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
-
Tubulis Presents First Clinical Data from Phase I/IIa Trial for TUB-040 in Platinum-Resistant Ovarian Cancer (PROC) at ESMO 2025
-
Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
-
Falcon Finance Publishes Strategy Allocation Breakdown for Yield Generation Transparency
-
The 2025 Chery International User Summit Opens a New Chapter as AiMOGA Robotics Unveils Its Global Brand Strategy
-
Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced
-
DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom
-
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
-
Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study
-
Wialon Announces Top 10 GPS Hardware Manufacturers for 2025
-
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
-
Arbrest Champions Sustainability with Solid Wood Furniture That Extends the Life of Trees
-
From Presentation to Full-Service Reception: AiMOGA Robot Demonstrates "Human Assistant" Capabilities at the 2025 Chery Global Innovation Conference
-
Guardians of Continuity The Key to Alpha Wealth's Lasting Prosperity
-
Divy Fashion Mart Introduces Investment Shopping for the Future
-
How Avast Helps Protect Millions From Online Scams, Malware, and Phishing in 2025 - Report by Expert Consumers
-
Metamorphosis Collective Announces Revolutionary 12 Week Program for High Achieving Women
-
The Underfront Co. Announces Wilmington's New Cocktail Destination
-
AdSolve Media Named Best Digital Marketing Agency in Edmonton
-
From Galloping Messengers to One-Click Delivery: The Lychee Journey from Chang'an to Today.
-
Harrah's Northern California Presents: Merry Millions - Win Up to $1 Million In Cash!
-
Springfield Energy Founder Kevin Okyere Calls for Shared Action as 12% of Ghanaians Face Food Insecurity
-
Pinnacle Funding Network Expands National DSCR Platform as Rates Hit Two-Year Low
-
Local Chattanooga Author Stephanie Pleasant Releases Powerful Memoir "Vestiges of Light"
-
Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results
-
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint
-
Crypto News (Live): From $0.0075 to $0.50? Blazpay’s AI Presale Heats Up as Solana and BNB Investors Seek New Gains
-
Aurion Biotech Achieves All Primary, Secondary, and Exploratory Endpoints in AURN001 Phase 1/2 CLARA Trial at 12 Months
-
Importance of Management Review Reports for ISO 27001 Certification
-
New to The Street Show #694 to Broadcast Tonight at 6:30 PM EST as Sponsored Programming on Bloomberg TV Featuring Stardust Power (NASDAQ:SDST), Spartan Equipment, Roadzen (NASDAQ:RDZN), Aeries Techno
-
Get Me to Costa Rica! Offers Life-Changing Travel Experience
-
Dr. Beran Parry and the Advanced Bio Solutions Group Become Global Natural Medicine Leaders!
-
HKUST Holds Congregation 2025 Conferring Honorary Doctorates on Five Distinguished Leaders
-
Unlock SEO Success with the New Search Atlas Wordpress Plugin
-
COME Mining Unleashes the Next Generation of Cloud Mining -- Powering BTC Machines with XRP and Earning Daily Rewards
-
Joshua Washington's Lee Malveaux Rolls Out S.O.K.R.A.H. Framework for Enterprise Teams
-
Raconteuse Skincare Unveils Sustainable Rituals That Blend Nature, Science, and Storytelling
-
Modern Renovation Trends Transforming Ottawa Homes in 2025
-
Sify Technologies to announce Financial Results for Second Quarter FY 2025-26 on Saturday, October 25, 2025
-
Slangate Pioneering Financial Fraud Recovery with Technology and Global Expertise
-
13th Annual Energy Day Festival Sparks STEM Interest Among Houston Students
